- Dihydroartemisinin regulates the immune system by promotion of CD8+ T lymphocytes and suppression of B cell responses
Ting Zhang et al, 2019, Sci. China Life Sci. CrossRef - Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
Renxin Yi et al, 2020 CrossRef - Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/β-Catenin Signaling Pathways
Xiuhua Wu et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef - Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats
Ming Tang et al, 2020 CrossRef - Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies.
Qingrong Li et al, 2021, Onco Targets Ther CrossRef - The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?
Mariana Medeiros et al, 2021, Cell. Mol. Life Sci. CrossRef - Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
Ran Yu et al, 2021, Front. Oncol. CrossRef - Development of Nanoscale Drug Delivery Systems of Dihydroartemisinin for Cancer Therapy: A Review
Ka Hong Wong et al, 2022, Asian Journal of Pharmaceutical Sciences CrossRef - A Cuproptosis Activation Scoring model predicts neoplasm-immunity interactions and personalized treatments in glioma
Bo Chen et al, 2022, Computers in Biology and Medicine CrossRef - null
Vasiliki Zoi et al, 2023 CrossRef - Dihydroartemisinin inhibits EMT of glioma via gene BASP1 in extrachromosomal DNA
Zhongyou Que et al, 2023, Biochemical and Biophysical Research Communications CrossRef - Dihydroartemisinin suppresses glioma growth by repressing ERRα-mediated mitochondrial biogenesis
Wenxin Zhang et al, 2023, Mol Cell Biochem CrossRef - Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways
Lianli Ni et al, 2024, Neoplasia CrossRef - Target prediction and potential application of dihydroartemisinin on hepatocarcinoma treatment
Wenjia Guo et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef